No Picture
DC Maryland Virginia Biotech Trending News

FDA Approves First Fecal Microbiota Product

FDA approves the first fecal microbiota product, Rebyota. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. It is for used after an […]

No Picture
News

BMS’ Zeposia and AbbVie’s Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn’s Disease Markets, Spherix Reports

Takeda’s Entyvio, Janssen’s Stelara, and AbbVie’s Humira leave the most on the table when first-line biologic or small molecule agents are prescribed in inflammatory bowel disease EXTON, Pa., Nov. 30, 2022 /PRNewswire/ — US gastroenterologists […]

No Picture
News

Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive

MONTPELLIER, France–(BUSINESS WIRE)–MedinCell (Paris:MEDCL) has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to […]

No Picture
DC Maryland Virginia Biotech Trending News

Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

Merck filed a lawsuit against Johns Hopkins University in Maryland federal court on Tuesday, arguing that the storied university obtained illegal patents as part of its research collaboration with the company and related to its […]